Five-year period prevalence and characteristics of anemia in a large us inflammatory bowel disease cohort

Journal of Clinical Gastroenterology

Volumn 50, Issue 8, 2016, Pages 638-643

  Koutroubakis, Ioannis E ^a   Ramos Rivers, Claudia ^a   Regueiro, Miguel ^a   Koutroumpakis, Efstratios ^a   Click, Benjamin ^a   Schwartz, Marc ^a   Swoger, Jason ^a   Baidoo, Leonard ^a   Hashash, Jana G ^a   Barrie, Arthur ^a   Dunn, Michael A ^a   Binion, David G ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

anemia; Crohn's disease; prevalence; ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IMMUNOMODULATING AGENT; IRON SACCHARATE; IMMUNOLOGIC FACTOR; IRON DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY SCORE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HARVEY BRADSHAW INDEX; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; ULCERATIVE COLITIS; ULCERATIVE COLITIS ACTIVITY INDEX; UNITED STATES; COMPLICATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IRON COMPOUNDS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 84944790589     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000417     Document Type: Article

References (30)

1. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000; 6: 142-150.
2. Stein J, Dignass AU. Management of iron deficiency anemia in inflammatory bowel disease-A practical approach. Ann Gastroenterol. 2013; 26: 104-113.
3. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011; 5: 381-391.
4. Høivik ML, Reinisch W, Cvancarova M, et al. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther. 2014; 39: 69-76.
5. Bager P, Befrits R, Wikman O, et al. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol. 2013; 48: 1286-1293.
6. Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012; 18: 513-519.
7. Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a crosssectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010; 4: 642-648.
8. Bager P, Befrits R, Wikman O, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011; 46: 304-309.
9. Sjöberg D, Holmström T, Larsson M, et al. Anemia in a Population-based IBD Cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis. 2014; 20: 2266-2270.
10. Kulnigg S, Gasche C. Systematic review: managing anemia in Crohn?s disease. Aliment Pharmacol Ther. 2006; 24: 1507-1523.
11. Filmann N, Rey J, Schneeweiss S, et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-Analysis. Inflamm Bowel Dis. 2014; 20: 936-945.
12. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007; 13: 1545-1553.
13. WHO, UNICEF, UNU. Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO/UNICEF/.UNU consultation. Geneva, Switzerland: World Health Organization 1998
14. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19(suppl A): 5-36.
15. Harvey RF, Bradshaw JM. A simple index of Crohn?s disease activity. Lancet. 1980; 1: 514.
16. D?Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007; 132: 763-786.
17. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004; 116(suppl 7A): 44S-49S.
18. Werlin SL, Grand RJ. Severe colitis in children and adolescents: diagnosis, course, and treatment. Gastroenterology. 1977; 73: 828-832.
19. Reilly J, Ryan JA, Strole W, et al. Hyperalimentation in inflammatory bowel disease. Am J Surg. 1976; 131: 192-200.
20. Greenstein AJ, Kark AE, Dreiling DA. Crohn?s disease of the colon: II. Controversial aspects of hemorrhage, anemia and rectal involvement in granulomatous disease involving the colon. Am J Gastroenterol. 1975; 63: 40-48.
21. Burbige EJ, Huang SH, Bayless TM. Clinical manifestations of Crohn?s disease in children and adolescents. Pediatrics. 1975; 55: 866-871.
22. Beeken WL. Remediable defects in Crohn disease: a prospective study of 63 patients. Arch Intern Med. 1975; 135: 686-690.
23. Beeken WL. Absorptive defects in young people with regional enteritis. Pediatrics. 1973; 52: 69-74.
24. Ershler WB, Chen K, Reyes EB, et al. Economic burden of patients with anemia in selected diseases. Value Health. 2005; 8: 629-638.
25. Bergamaschi G, Di SA, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-Tumor necrosis factor-Alpha treatment. Haematologica. 2010; 95: 199-205.
26. Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006; 12: 123-130.
27. Lee TW, Kolber MR, Fedorak RN, et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-Analysis. J Crohns Colitis. 2012; 6: 267-275.
28. Blumenstein I, Dignass A, Vollmer S, et al. Current practice in the diagnosis and management of IBD-Associated anaemia and iron deficiency in Germany: the German AnaemIBD Study. J Crohns Colitis. 2014; 8: 1308-1314.
29. Stein J, Bager P, Befrits R, et al. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol. 2013; 25: 1456-1463.
30. Dignass AU, Gasche C, Bettenworth D, et al. European Consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015; 9: 211-222.